Ceregene - Newsroom

2006 Press Releases

10.10.06	Ceregene Announces Promising Phase I Results from Gene Therapy Trial for Parkinson's Disease
10.10.06	Michael J. Fox Foundation Awards $1.9 Million to Support Ceregene Phase II Gene Therapy Clinical Trial.
06.13.06	Gene Therapy Injected into the Brains' of Mice with Huntington's Disease Protects Neurons, Stop Degeneration and Improves Behavioral Function